Ubs Group Ag Avrobio, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
BUY
$0.98 - $1.62 $9,614 - $15,893
9,811 Added 15093.85%
9,876 $15,000
Q4 2022

Feb 08, 2023
SELL
$0.64 - $0.91 $14,314 - $20,353
-22,366 Reduced 99.71%
65 $0
Q3 2022

Nov 10, 2022
BUY
$0.68 - $1.11 $15,253 - $24,898
22,431 New
22,431 $14,000
Q2 2022

Aug 10, 2022
SELL
$0.75 - $1.33 $1,857 - $3,293
-2,476 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.29 - $4.04 $3,239 - $10,144
-2,511 Reduced 50.35%
2,476 $3,000
Q4 2021

Feb 14, 2022
BUY
$3.45 - $6.05 $10,305 - $18,071
2,987 Added 149.35%
4,987 $19,000
Q3 2021

Nov 15, 2021
SELL
$5.53 - $9.28 $22,120 - $37,120
-4,000 Reduced 66.67%
2,000 $11,000
Q2 2021

Aug 13, 2021
BUY
$7.84 - $12.6 $44,413 - $71,379
5,665 Added 1691.04%
6,000 $53,000
Q1 2021

May 12, 2021
SELL
$10.54 - $19.3 $15,894 - $29,104
-1,508 Reduced 81.82%
335 $4,000
Q4 2020

Feb 11, 2021
BUY
$12.79 - $17.1 $23,571 - $31,515
1,843 New
1,843 $26,000
Q3 2020

Nov 12, 2020
SELL
$12.99 - $19.41 $15,302 - $22,864
-1,178 Closed
0 $0
Q2 2020

Jul 31, 2020
SELL
$12.19 - $22.96 $2.02 Million - $3.81 Million
-165,898 Reduced 99.29%
1,178 $20,000
Q1 2020

May 01, 2020
BUY
$10.08 - $27.21 $1.67 Million - $4.51 Million
165,756 Added 12557.27%
167,076 $2.6 Million
Q4 2019

Feb 14, 2020
SELL
$13.05 - $21.88 $684,655 - $1.15 Million
-52,464 Reduced 97.55%
1,320 $27,000
Q3 2019

Nov 14, 2019
SELL
$14.12 - $23.44 $52,498 - $87,149
-3,718 Reduced 6.47%
53,784 $759,000
Q2 2019

Aug 14, 2019
BUY
$13.21 - $27.29 $250,369 - $517,227
18,953 Added 49.17%
57,502 $935,000
Q1 2019

May 14, 2019
BUY
$12.46 - $22.05 $477,703 - $845,374
38,339 Added 18256.67%
38,549 $850,000
Q4 2018

Feb 14, 2019
SELL
$15.43 - $32.7 $22,327 - $47,316
-1,447 Reduced 87.33%
210 $4,000
Q3 2018

Nov 14, 2018
SELL
$26.95 - $52.7 $2,479 - $4,848
-92 Reduced 5.26%
1,657 $86,000
Q2 2018

Aug 14, 2018
BUY
$28.08 - $31.2 $49,111 - $54,568
1,749 New
1,749 $50,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email